ArticleBiophysical journal2025
Decoding SP-D and glycan binding mechanisms using a novel computational workflow.
Article in Biophysical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Surfactant protein D (SP-D) plays an important role in the innate immune system by recognizing and binding to glycans on the surface of pathogens, facilitating their clearance. Despite its importance, the detailed binding mechanisms between SP-D and various pathogenic surface glycans remain elusive due to the limited experimentally solved protein-glycan crystal structures. To address this, we developed and validated a computational workflow that integrates induced fit docking, molecular mechanics/generalized Born surface area binding free energy calculations, and binding pose metadynamics simulations to accurately predict stable SP-D-glycan complex structure and binding mechanisms. By utilizing this workflow, we identified primary and secondary binding sites in SP-D critical for glycan recognition and uncovered a calcium chelation mode correlating with high binding affinity. To demonstrate the workflow's utility, we investigated the binding of pilin glycan from Pseudomonas aeruginosa (P. aeruginosa) to SP-A, SP-D, and mannose-binding lectin (MBL). We found that SP-D exhibited the most stable binding with pilin glycan versus SP-A and MBL, highlighting its potential role in the innate immune response against P. aeruginosa infection. These findings deepen our understanding of SP-D's role in the innate immune response and provide a basis for engineering SP-D variants for therapeutic applications. Moreover, our computational workflow can serve as a powerful tool for exploring protein-ligand interactions in diverse, biologically significant systems. It provides a robust framework to guide experimental studies and accelerates the development of novel therapeutics, effectively bridging the gap between computational insights and practical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.